Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
Subjects will be given an informed consent to read and sign The medical chart will be
reviewed for diagnosis and treatment history Blood (about 4 tablespoons) will be drawn at a
clinically available time. The lymph node and breast tumor tissue in the University of
Michigan pathology repository will be used for research purposes
Observational
Time Perspective: Prospective
Catherine Van Poznak, MD
Principal Investigator
University of Michigan Cancer Center
United States: Institutional Review Board
UMCC 2008.066
NCT00858585
March 2009
January 2015
Name | Location |
---|---|
University of Michigan | Ann Arbor, Michigan 48109-0624 |